Product Information

MIMVEY 1-0.5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.5488 per EA under NDC 00093545528. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on May 11, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Estradiol and Norethindrone Acetate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MIMVEY 1-0.5 MG TABLET

Estradiol and Norethindrone Acetate
$0.5488per EA
Low Outlier

Strength

1; .5 mg/1; mg/1

NDC

00093545528

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA079193

FDA Approved

5/11/2010

TE Code

AB

On Market Since

6/2/2010

Pharmacological Classes

Estradiol Congeners
Estrogen Receptor Agonists
Estrogen
Progesterone Congeners
Progestin

Price Statistics

The NADAC for MIMVEY 1-0.5 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 79.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5488 per EA
All-time high$3.8449 (Oct 15, 2014)
All-time low$0.4012 (Nov 20, 2024)
52-week high$0.7650
52-week low$0.5488
Median price$2.0359
Average price$1.9477
Largest weekly change+78.2% (Aug 21, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-8.1%

1M

-3.7%

3M

-14.4%

6M

-21.7%

1Y

-19.0%

3Y

-25.9%

5Y

-59.3%

All

-79.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MIMVEY 1-0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MIMVEY 1-0.5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.5488 per EA (NDC 00093545528), effective Nov 18, 2026.

How has the price of MIMVEY 1-0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for MIMVEY 1-0.5 MG TABLET has declined 79.7%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MIMVEY 1-0.5 MG TABLET?

Since Nov 28, 2013, the NADAC for MIMVEY 1-0.5 MG TABLET has ranged from a low of $0.4012 (Nov 20, 2024) to a high of $3.8449 (Oct 15, 2014), with a median of $2.0359 per EA.

Are there cheaper alternatives to MIMVEY 1-0.5 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIMVEY 1-0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MIMVEY 1-0.5 MG TABLET?

MIMVEY 1-0.5 MG TABLET (NDC 00093545528) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.